Home / Inspections / 1241780

FDA Inspection 1241780 — Aurobindo Pharma Limited

Aurobindo Pharma Limited — FEI 3004446312

The FDA completed an inspection of Aurobindo Pharma Limited on March 9, 2023 in Medchal. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 9, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Medchal (India)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1286862 (OAI Fri Sep 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1118385 (VAI Fri Feb 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1046218 (VAI Fri Mar 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 847151 (NAI Fri Aug 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 793023 (VAI Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources